A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Condition: Patient of Anemia in Chronic Renal Failure With Hemodialysis Interventions: Drug: RD01; Drug: Recombinant Human Erythropoiesis Injection (CHO cell); Drug: placebo Sponsor: Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials